NEW YORK (Reuters) - U.S. companies are hoarding almost $1 trillion in cash but are unlikely to spend on expanding their business and hiring new employees due to continuing uncertainty about the strength of the economy, Moody’s Investors Service said on Tuesday.
As the economy stabilizes companies are also more likely to spend on share repurchases and mergers and acquisitions, Moody’s added.
Companies cut costs, reduced investment in plants and equipment and downsized operations in order to boost cash holdings during the recession. As the corporate bond market reopened many companies also boosted cash levels by selling debt and refinancing near-term debt maturities.
Nonfinancial U.S. companies are sitting on $943 billion of cash and short-term investments, as of mid-year 2010, compared with $775 billion at the end of 2008, Moody’s said. This would be enough to cover a year’s worth of capital spending and dividends and still have $121 billion left over, it said.
However, “we believe companies are looking for greater certainty about the economy and signs of a permanent increase in sales before they let go of their cash hoards, which they suffered so much to build,” Moody’s said in a report.
“Given low demand and capacity utilization within certain industries, companies are wary of investing their cash in new capacity and adding workers, thereby doing little to abbreviate the jobless recovery,” it added.
Around one quarter of the cash is held overseas and is unlikely to be repatriated to the United States, Moody’s said.
Meanwhile only 20 companies hold a large portion of corporate cash balances, with $346 billion on their balance sheets, or 37 percent of the total, Moody’s said.
Cisco Systems CSCO.O has the largest cash balance, at $39.86 billion, while Microsoft MSFT.O is second with $36.79 billion, Moody's said. Google GOOG.O has the third-largest balance with $30.06 billion, followed by Oracle ORCL.O with $23.64 billion and Ford Motor Co F.N at $21.89 billion.
Technology companies held the most cash as a sector, at $207 billion, followed by pharmaceuticals with $124 billion, energy at $105 billion, and consumer products with $101 billion, Moody’s said.
Reporting by Karen Brettell; Editing by James Dalgleish
Our Standards: The Thomson Reuters Trust Principles.